What is the recommended ketorolac dosage and IV drip administration for an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ketorolac IV Dosing and Administration

For adult patients, administer ketorolac IV as a 30 mg bolus over at least 15 seconds for patients <65 years, or 15 mg for patients ≥65 years, renally impaired, or <50 kg, with multiple dosing every 6 hours not exceeding 5 days total duration. 1

Single-Dose Regimen

IV Administration:

  • Patients <65 years: 30 mg IV bolus
  • Patients ≥65 years, renally impaired, or <50 kg: 15 mg IV bolus
  • Must be given over no less than 15 seconds 1
  • Analgesic effect begins in ~30 minutes, peaks at 1-2 hours, lasts 4-6 hours 1

Multiple-Dose Regimen

For continued pain management:

  • Patients <65 years: 30 mg IV every 6 hours (maximum 120 mg/day)
  • Patients ≥65 years, renally impaired, or <50 kg: 15 mg IV every 6 hours (maximum 60 mg/day)
  • Total duration limit: 5 days maximum (combined IV/IM and oral) 1

IV Drip/Continuous Infusion

Ketorolac is NOT typically given as a continuous IV drip in standard practice. The FDA labeling specifies bolus administration only 1. However, one older study demonstrated that a 30 mg IV bolus followed by 5 mg/hour continuous infusion for 24 hours reduced morphine consumption by 35-44% after orthopedic surgery 2. This approach is not FDA-approved and should only be considered in specialized postoperative settings with appropriate monitoring.

Critical Safety Considerations

Correct hypovolemia BEFORE administering ketorolac 1. The drug carries significant risks:

  • GI bleeding risk is dose-dependent and dramatically increases with doses >60 mg/day, especially in elderly patients (7.7% incidence in patients ≥65 years receiving >120 mg/day) 1
  • Do NOT mix in syringe with morphine, meperidine, promethazine, or hydroxyzine—causes precipitation 1
  • Monitor for renal failure, bleeding complications, and hepatic dysfunction 1

Evidence-Based Dosing Insights

Recent high-quality research challenges traditional dosing. Lower doses (10-15 mg) provide equivalent analgesia to 30 mg in emergency department patients with acute pain 3, 4, 5. A 2023 systematic review found no difference in pain relief between 15-20 mg versus ≥30 mg doses 3. Similarly, a 2021 trial demonstrated that 10 mg, 20 mg, and 30 mg produced identical pain reduction in renal colic 4.

Despite this evidence, the FDA-approved dosing remains 30 mg for standard adult patients 1, and guidelines support using ketorolac as part of multimodal analgesia to reduce opioid consumption 6. The 2018 Critical Care Medicine guidelines suggest using NSAIDs like ketorolac as adjuncts to decrease opioid-related complications 6.

Practical Algorithm

  1. Assess patient factors: Age, weight, renal function, bleeding risk, volume status
  2. Correct hypovolemia first if present
  3. Choose dose:
    • Standard adult (<65 years, >50 kg, normal renal function): 30 mg IV
    • High-risk patient (≥65 years, <50 kg, or renal impairment): 15 mg IV
  4. Administer over ≥15 seconds
  5. If multiple doses needed: Repeat every 6 hours at same dose
  6. Transition to oral or discontinue by day 5
  7. Consider lower doses (10-15 mg) for patients at higher risk of adverse events, though this is off-label

Do not increase dose or frequency for breakthrough pain—supplement with low-dose opioids instead 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.